STEAP1 CART Cell Therapy(PromiCell)

N/A

Report date: 2024/02/02 20:04:50

Base Information

Drug NameSTEAP1 CART Cell Therapy(PromiCell)
Drug Alias NameAnti-STEAP1 CAR T-cells Therapy(PromiCell)STEAP1-targeting CAR T-cells Therapy(PromiCell)STEAP1 CAR-T Cells Therapy(PromiCell)Anti-STEAP1 CAR-T Cells Therapy(PromiCell)Anti-STEAP1 CAR T Cells Therapy(PromiCell)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacementsAnti-STEAP1
TargetsSix-transmembrane epithelial antigen of the prostate 1
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPromiCell Therapeutics IncFred Hutchinson Cancer Research Center
China Registration ClassN/A

Develop Information

Active CompaniesPromiCell Therapeutics IncFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A